Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction A feasible surrogate trial endpoint? A report from the prospective Karen study (vol 226, pg 65, 2017)

Gianluigi Savarese (1) , Erwan Donal (2, 3) , Camilla Hage (1) , Emmanuel Oger (4) , Hans Persson (1) , Jean-Claude Daubert (3) , Cecilia Linde (1) , Lars H. Lund (1)

1 Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden
2 Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes]
3 LTSI - Laboratoire Traitement du Signal et de l'Image
4 CIC - Centre d'Investigation Clinique [Rennes]

Domains: Life Sciences [q-bio]; Bioengineering; Life Sciences [q-bio]

Gianluigi Savarese, Erwan Donal, Camilla Hage, Emmanuel Oger, Hans Persson, et al.. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction A feasible surrogate trial endpoint? A report from the prospective Karen study (vol 226, pg 65, 2017). International Journal of Cardiology, 2018, 261, pp.240. ⟨10.1016/j.ijcard.2018.03.075⟩. ⟨hal-01806802⟩